Page 7 - Embecta Corp News Today

Versor Investments LP bought a new stake in Embecta Corp. (NASDAQ:EMBC – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 20,853 shares of the company’s stock, valued at approximately $586,000. A number of other institutional investors and […]

Continues Strong Performance and Progress Toward Achieving BD 2025 Strategy; Advances Innovation Pipeline and Receives Clearance for Updated BD Alaris™...

/PRNewswire/ -- In the near future, the insulin delivery devices industry is poised for remarkable advancements that promise to revolutionize diabetes...

The global lancets market has an estimated compound annual growth rate (CAGR) of 9.7% and a revenue size in the region of $2.3 billion in 2023.

Embecta Corp. (NASDAQ:EMBC – Get Free Report) was up 2.7% during trading on Friday . The company traded as high as $21.22 and last traded at $21.05. Approximately 97,394 shares were traded during trading, a decline of 84% from the average daily volume of 614,605 shares. The stock had previously closed at $20.49. Embecta Trading […]

PARSIPPANY, N.J., July 11, 2023 -- Embecta Corp. , a global diabetes care company, will host a conference call to discuss its fiscal third quarter 2023 financial results, provide an operational...

Ra Medical Systems (NYSE:RMED – Free Report) and Embecta (NASDAQ:EMBC – Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership. Valuation & Earnings This table compares Ra Medical Systems […]

Embecta Corp. (NASDAQ:EMBC – Free Report) shares dropped 3.1% on Friday . The company traded as low as $21.88 and last traded at $21.88. Approximately 151,786 shares were traded during trading, a decline of 76% from the average daily volume of 622,948 shares. The stock had previously closed at $22.58. Embecta Trading Down 2.5 % […]

Embecta Corp. (NASDAQ:EMBC – Get Rating) was down 3.3% during mid-day trading on Friday . The company traded as low as $25.42 and last traded at $25.42. Approximately 106,527 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 610,279 shares. The stock had previously closed at $26.29. Embecta […]

Embecta Corp. (NASDAQ:EMBC – Get Rating) shares traded down 3.3% during mid-day trading on Friday . The stock traded as low as $25.42 and last traded at $25.42. 106,527 shares were traded during trading, a decline of 83% from the average session volume of 610,279 shares. The stock had previously closed at $26.29. Embecta Trading […]